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Squamous cell carcinomas of the uterine cervix frequently develop
hypoxic regions during growth (Höckel et al, 1991; Brizel et al,
1995; Wong et al, 1997; Cooper et al, 1999; Dunst et al, 1999).
Hypoxia may cause resistance to radiation therapy (Stone et al,
1993) and increased metastatic propensity (Hill, 1990). Several
studies of advanced cervix carcinoma have demonstrated a posi-
tive association between poor outcome of radiation therapy and
poor oxygenation of the primary tumour, measured with the
Eppendorf  pO2 histograph prior to treatment (Höckel et al, 1993;
1996; Fyles et al, 1998a; 1998b). The worse treatment outcome of
the patients with the most hypoxic tumours could be related to the
classical oxygen effect (Bush, 1986; Overgaard et al, 1989) or to
the development of metastases associated with hypoxia (Höckel et
al, 1996; Sundfør et al, 1998).
Identification of the primary cause of treatment failure in
advanced cervix carcinoma may facilitate the development of
improved treatment strategies for this disease. Thus, if treatment
failure is primarily a result of hypoxia-induced radiation
resistance, treatment strategies aiming at improving tumour
oxygenation or enhancing the radiation sensitivity of hypoxic cells
may prove beneficial. On the other hand, if treatment failure is
primarily a result of the presence of hypoxia-induced metastases at
the start of treatment, other strategies are required to improve the
outcome of treatment.
Studies at The Norwegian Radium Hospital have confirmed that
poor outcome of treatment of advanced cervix carcinoma is asso-
ciated with poor oxygenation of the primary tumour; tumour
hypoxia was identified as an important prognostic factor for
locoregional control, disease-free survival and overall survival
(Sundfør et al, 2000). In the present work, the outcome of radiation
therapy of advanced cervix carcinoma was investigated in relation
to pretreatment oxygenation and metastatic status, in an attempt
to reveal whether treatment failure is primarily a conse-
quence of hypoxia-induced radiation resistance or hypoxia-
induced metastasis.
MATERIALS AND METHODS
Patients and treatment
Thirty-two consecutive patients with squamous cell carcinoma
of the uterine cervix were included in the study. The inclusion
criteria required that: (a) the largest diameter of the primary
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tumour, determined from pretreatment magnetic resonance (MR)
images, was 2 cm or more; (b) the patients were less than 70 years
of age; (c) the patients met the criteria for anaesthesia function
class ASA I or ASA II; and (d) the patients were subjected to radi-
ation therapy without surgery of the primary tumour. Important
characteristics of the patients are listed in Table 1. Clinical stage
was determined according to the FIGO criteria. Pretreatment
tumour volume (V) was calculated as V = p/6°a°b°c, where a, b and
c are three orthogonal diameters determined from MR images. The
study was approved by the local ethical commitee, and informed
consent was achieved from the patients.
The metastatic status of the patients was assessed at the time of
initial diagnosis. Pelvic and para-aortal lymph-node metastases
were detected by MR imaging. Lymph nodes were considered
pathological when the minimal axial diameter was 10 mm or more
or when the minimal axial diameter was 8–10 mm and the lymph
nodes were judged to be round. The sensitivity, specificity, accu-
racy and positive predictive value of these criteria in assessment of
the metastatic status of lymph nodes have been shown to be high
(Jager et al, 1996).
Radiation therapy was given with curative intent as combined
external irradiation and endocavitary brachytherapy. The external
irradiation was delivered with a 10 or 16 MV linear accelerator.
The total dose was 50 Gy, given to the pelvic region with a four-
field box technique in daily fractions of 2 Gy five times a week.
The brachytherapy was delivered with a high dose-rate 192Ir after-
loading machine. The total dose was 29–34 Gy, given to point A in
7–8 fractions. The follow-up included clinical examinations every
third month for the first 2 years and thereafter every sixth month.
MR of retroperitoneum and X-ray of thorax were performed
during the first examination, after 2 months, after 1 year and when
symptoms of recurrent disease were seen. Three end-points were
used: overall survival, disease-free survival and locoregional
control. Locoregional control was defined as complete and persis-
tent tumour remission within the radiation field. The median
follow-up, calculated from the start of treatment, was 50 months
(range 31–69 months).
Oxygen tension
Tumour oxygen tension (pO2) was measured before treatment
using a polarographic needle electrode (Eppendorf pO2 Histograph
6650) (Sundfør et al, 1997). Heart rate, arterial blood pressure
and arterial HbO2 saturation were recorded throughout the pO2
measurements. A total of 57–252 pO2 readings in 2–6 tracks were
performed in each tumour. The tracks were located peripherally
(clock positions 3, 6, 9 and 12) or centrally and were directed
perpendicularly to the tumours. The track lengths were determined
by the tumour size, measured by analysing MR images. A pO2
frequency distribution was generated for each tumour by pooling
the data from the individual tracks. Three pO2 parameters were
derived from the tumours: median pO2, the fraction of the pO2
readings giving pO2 values below 5 mmHg (HF (pO2 < 5 mmHg))
and the tumour subvolume having pO2 values below 5 mmHg
(HSV (pO2 < 5 mmHg)), where HSV (pO2 < 5 mmHg) = HF (pO2
< 5 mmHg) ´ V (tumour volume).
Statistical analysis
Volume and oxygenation parameters of metastatic and non-
metastatic tumours were compared by using the Student’s t-test.
Probabilities of locoregional control, disease-free survival or
overall survival of two groups of patients were compared by actu-
arial analysis, using a log-rank test in Kaplan–Meier estimates.
Univariate and multivariate Cox regression analyses of continuous
or categorical data were used to evaluate the prognostic value of
tumour parameters. The prognostic value of tumour stage was
investigated by joining stage 1 and 2 in one group and stage 3 and
4 in a second group. A significance criterion of P < 0.05 was used.
RESULTS
Tumour oxygenation status differed substantially among indi-
vidual patients, although all tumours were highly heterogenous in
pO2. Median pO2, HF (pO2 < 5 mmHg) and HSV (pO2 < 5 mmHg)
of each individual patient are presented in Table 1 together with
FIGO stage, tumour volume, number of pathological lymph nodes,
observation time and outcome of treatment in terms of loco-
regional control, disease-free survival and overall survival.
Eighteen of the 32 patients had developed regional lymph-node
metastases at the time of initial diagnosis. The number of patho-
logical lymph nodes in these patients ranged from 1–8 (Table 1).
Metastases could not be detected in the remaining 14 patients.
Tumour oxygenation status differed substantially between the
patients with metastases and the patients without metastases.
The patients with metastases showed a significantly higher HSV
(pO2 < 5 mmHg) (P = 0.002) and a significantly higher HF
(pO2 < 5 mmHg) (P = 0.03) than the patients without metastases
(Figure 1). On the other hand, median tumour pO2 did not differ
significantly between the two groups of patients.
HSV (pO2 < 5 mmHg) was correlated to tumour volume
(P < 0.001), as revealed by linear regression analysis. Tumour
volume differed substantially between the patients with metastases
and the patients without metastases as did HSV (pO2 < 5 mmHg);
the patients with metastases showed a significantly larger tumour
volume (P = 0.01) than those without metastases (data not shown).
The P-value of 0.002 pertaining to HSV (pO2 < 5 mmHg) was
substantially lower than that of 0.01 pertaining to tumour volume,
suggesting that the discriminative power of HSV (pO2 < 5 mmHg)
was higher than that of tumour volume. There was no correlation
between HF (pO2 < 5 mmHg) and tumour volume (P = 0.12).
Univariate Cox regression analysis showed that disease-free
survival was correlated to the number of pathological lymph nodes
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Figure 1 (A) HSV (pO2 < 5 mmHg) and (B) HF (pO2 < 5 mmHg) of the
primary tumour of 32 patients with advanced squamous cell carcinoma of the
uterine cervix. Patients with metastases and patients without metastases at
the time of pO2 measurement are compared. Points represent individual
patients.Radiation therapy of cervix carcinoma 357
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at the time of initial diagnosis, whereas locoregional control and
overall survival were not (Table 2). Moreover, neither locoregional
control, disease-free survival nor overall survival was correlated to
metastatic status, i.e. the patients were catagorized as either meta-
stasis positive or metastasis negative (Table 2). The probabilities
of locoregional control, disease-free survival and overall survival
were not significantly worse for the patients with metastases than
for the patients without metastatic deposits at the start of treatment
(P = 0.7, P = 0.3 and P = 0.5, respectively), as illustrated by
Kaplan–Meier plots in Figure 2.
Locoregional control, disease-free survival and overall survival
showed significant correlations to HSV (pO2 < 5 mmHg), as
revealed by univariate Cox regression analysis (Table 2). In
contrast, significant correlations between locoregional control,
disease-free survival or overall survival on the one hand and HF
(pO2 < 5 mmHg) or median pO2 on the other were not found
(Table 2). The probabilities of locoregional control, disease-free
survival and overall survival were significantly lower for the
patients with HSV (pO2 < 5 mmHg) above the median value than
for those with HSV (pO2 < 5 mmHg) below the median value
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Figure 2 Kaplan–Meier plots showing probability of (A, B) locoregional control, (C, D) disease-free survival and (E, F) overall survival for 32 patients with
advanced squamous cell carcinoma of the uterine cervix. Patients with metastases and patients without metastasis at the start of radiation therapy are
compared (A, C, E) and patients with HSV (pO2 < 5 mmHg) above and HSV (pO2 < 5 mmHg) below the median value are compared (B, D, F). Median HSV
(pO2 < 5 mmHg) was 40 cm3. Censored observations are indicated as t t or s s.
Table 2 Results of univariate Cox regression analysis
P-value
Parameter Locoregional Disease-free Overall
control survival survival
Metastatic status (+/–) 0.71 0.34 0.46
Pathol. nodes (n) 0.18 0.0068 0.086
Median pO2 0.28 0.14 0.23
HF (pO2 < 5 mmHg) 0.22 0.056 0.14
HSV (pO2 < 5 mmHg) 0.016 <0.0001 0.0010
FIGO stage 0.18 0.043 0.040
Tumour volume 0.020 0.0001 0.0014358 EK Rofstad et al
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(P = 0.04, P = 0.001 and P = 0.005, respectively), as illustrated by
Kaplan–Meier plots in Figure 2.
Univariate Cox regression analysis showed that locoregional
control was correlated to tumour volume, and disease-free survival
and overall survival were correlated to FIGO stage and tumour
volume (Table 2). Moreover, multivariate Cox regression analysis
including number of pathological lymph nodes, metastatic status,
HSV (pO2 < 5 mmHg), HF (pO2 < 5 mmHg), FIGO stage and
tumour volume identified HSV (pO2 < 5 mmHg) as the only inde-
pendent prognostic factor for locoregional control (P = 0.006;
relative risk per cm3 = 1.04), disease-free survival (P < 0.0001;
relative risk per cm3 = 1.03) and overall survival (P = 0.001;
relative risk per cm3 = 1.02).
DISCUSSION
The present study confirmed the results of previous studies
suggesting that tumour oxygenation status is an important prog-
nostic factor in advanced cervix carcinoma (Höckel et al, 1993;
1996; Fyles et al, 1998a; 1998b). Median pO2 and HF (pO2
< 5 mmHg) were used as parameters for tumour oxygenation
status in these previous studies. In the present study, HSV (pO2
< 5 mmHg) was found to have a higher prognostic value than
median pO2 or HF (pO2 < 5 mmHg), irrespective of whether
locoregional control, disease-free survival or overall survival was
used as end-point. HSV (pO2 < 5 mmHg) has not been recognized
as a prognostic factor in advanced cervix carcinoma previously.
However, our observation is consistent with the results from a
similar study of squamous cell carcinoma of the head and neck
(Stadler et al, 1999). In this study, oxygen tension was measured in
primary tumours in 26 patients and in lymph-node metastases in
33 patients, and multivariate Cox regression analysis identified
HSV (pO2 < 5 mmHg) as a significant prognostic factor for overall
survival.
The study reported here suggests that a high incidence of
lymph-node metastases is associated with poor oxygenation of the
primary tumour in advanced cervix carcinoma. Thus, the tumours
of the patients with metastases at the time of initial diagnosis
showed a higher HSV (pO2 < 5 mmHg) and a higher HF (pO2
< 5 mmHg) than those of the patients without metastases. This
observation is consistent with data from a study of advanced
cervix carcinoma by Höckel et al (1996) showing that tumours
with a median pO2 < 10 mmHg have significantly larger exten-
sions, more frequent parametrial infiltration and more extensive
lymph–vascular space involvement than tumours with a median
pO2 > 10 mmHg. Moreover, our data is also consistent with the
observation that a high lactate concentration in the primary tumour
is associated with a high incidence of metastases in advanced
cervix carcinoma (Schwickert et al, 1995).
One possible interpretation of our observation is that tumour
hypoxia may promote lymph node metastasis in cervix carcinoma.
This interpretation is supported by results from studies of experi-
mental tumours. Thus, exposure of tumour cells to hypoxia in vitro
before intravenous inoculation in mice has been shown to increase
the frequency of lung colonies in murine tumours (Young et al,
1988) and human melanoma xenografts (Rofstad and Danielsen,
1999). Several mechanisms have been identified that may be
involved in hypoxia-induced metastasis of tumours (Rofstad,
2000). Thus, hypoxia may induce point mutations and DNA strand
breakage leading to deletions, amplifications and genomic insta-
bility. Hypoxia may also provide a physiological pressure in
tumours selecting for metastatic cell phenotypes. Moreover,
hypoxia may induce a temporary increase in the expression of
gene products involved in the metastatic cascade, either through
gene amplifications or through normal physiological processes by
activating oxygen sensors, hypoxia signal transduction pathways
and DNA transcription factors (Rofstad, 2000).
The present study showed that the outcome of treatment was
associated with FIGO stage, tumour volume and tumour oxygen-
ation status prior to treatment, consistent with previous studies of
advanced cervix carcinoma (Höckel et al, 1993; 1996; Fyles et al,
1998a; 1998b). In the study reported here, tumour oxygenation
status, measured as HSV (pO2 < 5 mmHg), showed a higher prog-
nostic value than both FIGO stage and tumour volume. Thus, HSV
(pO2 < 5 mmHg) was found to be the only independent prognostic
factor for locoregional control, disease-free survival and overall
survival in multivariate Cox regression analyses involving a large
number of biological and clinical parameters. Moreover, the prob-
abilities of locoregional control, disease-free survival and overall
survival were significantly lower for the patients with HSV
(pO2 < 5 mmHg) above the median value than for those with HSV
(pO2 < 5 mmHg) below the median value. These observations
suggest that measurement of tumour oxygen tension with the
Eppendorf  pO2 histograph prior to treatment may be a useful prog-
nostic test in advanced cervix carcinoma.
Hypoxia-induced treatment failure was primarily a result of
hypoxia-induced radiation resistance rather than the presence of
hypoxia-induced metastases at the start of treatment. This conclu-
sion follows from the Kaplan–Meier plots in Figure 2, which show
that the outcome of treatment was significantly worse for the
patients with HSV (pO2 < 5 mmHg) above the median value than
for those with HSV (pO2 < 5 mmHg) below the median value,
whereas the outcome of treatment was not significantly different
for the patients with metastases and the patients without meta-
stases at the start of treatment. Moreover, univariate Cox regres-
sion analyses revealed strong correlations between outcome of
treatment and HSV (pO2 < 5 mmHg), irrespective of clinical end-
point, whereas a significant correlation between outcome of treat-
ment and metastatic status was not found for any of the end-
points. Finally, multivariate Cox regression analysis involving
several biological and clinical parameters showed that HSV
(pO2 < 5 mmHg) was the only independent prognostic factor for
outcome of treatment, irrespective of end-point. This does not
mean that the outcome of treatment was not influenced by the
presence of metastases at the start of treatment. In fact, a strong
correlation was found between disease-free survival and number
of pathological lymph nodes in univariate Cox regression analysis,
suggesting that the presence of lymph-node metastases at the start
of treatment indeed represents a therapeutic problem in advanced
cervix carcinoma.
Novel strategies are required to improve the radiation therapy of
advanced cervix carcinoma. The study reported here has signifi-
cant implications for the choice of strategy. Our data suggest that
treatment failure is primarily a consequence of the presence of
hypoxic cells in the primary tumour during the radiation therapy
rather than the presence of pathological lymph nodes at the start of
treatment. Strategies aiming at improving the oxygenation of the
primary tumour during the radiation therapy may therefore prove
beneficial. Such strategies may involve the use of agents which
improve the oxygen-carrying capacity of the blood, increase
tumour blood-flow and/or decrease the respiration rate of the
tumour cells (Vaupel, 1990; Horsman, 1995). Other potentiallyRadiation therapy of cervix carcinoma 359
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useful strategies include strategies aiming at killing or enhancing
the radiation sensitivity of hypoxic cells in the primary tumour,
possibly involving the use of hypoxia-selective cytotoxins (Brown
and Giaccia, 1998) and/or hypoxic cell radiosensitizers (Coleman,
1988). This suggestion is consistent with the observation that
patients with advanced cervix carcinoma with local treatment
failure show a significantly higher incidence of metastatic disease
following treatment and a significantly lower overall survival rate
than those with local treatment control (Fagundes et al, 1992;
Leibel and Fuks, 1992). It should be noticed, however, that
improved locoregional control or overall survival could not be
demonstrated in clinical trials of advanced cervix carcinoma
investigating potential therapeutic benefits of nitroimidazole
hypoxic cell radiosensitizers (Overgaard, 1994).
In conclusion, hypoxia in the primary tumour may promote
lymph-node metastasis and cause radiation resistance in cervix
carcinoma. Treatment failure in advanced cervix carcinoma is
primarily a result of hypoxia-induced radiation resistance rather
than the presence of hypoxia-induced lymph-node metastases at
the start of treatment.
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